Antonius Arnoldus Christiaan Jacobs

USPTO Granted Patents = 27 (Patent Applications = 14)

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 18 (Patent Applications = 35)

Average Co-Inventor Count = 1.6

ph-index = 3

Forward Citations = 31(Granted Patents)

Location History:

Boxmeer, NL (2009 - 2017)
Kessel, NL (2004 - 2024)

Company Filing History:

Intervet International B.v.

Internet International B.u.

patent

5. 1 out of 832,718

Other

patents

where one patent can have more than one assignee

Years Active: 2004-2025

Loading Chart...

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12383610 - Vaccine for protection againstserotype 9, sequence type 16 (2025-08-12),

2. 12295999 - Vaccine for protection against (2025-05-13),

3. 12023374 - Vaccine for protection against (2024-07-02),

4. 11696944 - Vaccine for protection against (2023-07-11),

5. 11607447 - Combination vaccine (2023-03-21),

6. 11311614 - Vaccines containing swine pathogens for associated non-mixed use (2022-04-26),

7. 11167021 - Vaccine for protection against (2021-11-09),

8. 11135285 - Swine vaccine (2021-10-05),

9. 11103569 - Vaccine for protection against (2021-08-31),

10. 10751405 - Vaccine for use against subclinicalinfection in a pig (2020-08-25),

11. 10751403 - Vaccine for protection against (2020-08-25),

12. 10265392 - [object Object] (2019-04-23),

13. 10130699 - Vaccine against Lawsonia intracellularis and porcine circovirus 2 (2018-11-20),

14. 9662382 - Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida (2017-05-30),

15. 9642905 - Vaccine to protect a ruminant against pneumonia caused by mannheimia haemolytica (2017-05-09),

Title: Antonius Arnoldus Christiaan Jacobs: Innovator in Veterinary Vaccines

Introduction: Antonius Arnoldus Christiaan Jacobs, based in Kessel, Netherlands, is a remarkable inventor with a significant impact in the veterinary field. With an impressive portfolio of 25 patents, Jacobs has dedicated his career to advancing vaccine technology, particularly in the protection of pigs against various infections.

Latest Patents: Among his latest innovations, Jacobs has developed a vaccine comprising an IgM protease antigen. This invention is designed for use in a method for protecting pigs against infections, specifically targeting serotype 2 and serotype 14 pathogens. His work on these vaccines underscores his commitment to enhancing animal health and welfare through innovative solutions.

Career Highlights: Antonius Jacobs has had a diverse career, contributing his expertise to leading companies in the veterinary industry. He has played a pivotal role at Intervet Inc. and Intervet International B.V., where his focus on vaccine development has greatly influenced practices in animal health.

Collaborations: Throughout his career, Jacobs has collaborated with esteemed colleagues in the field, including Paul Vermeij and Carla Christina Schrier. These partnerships have fostered a rich environment for innovation, allowing for the exchange of ideas that drive advancements in veterinary medicine.

Conclusion: Antonius Arnoldus Christiaan Jacobs exemplifies the spirit of innovation in the veterinary industry. His contributions through patents and collaborations continue to shape the future of animal health, ensuring better protection and care for livestock. With ongoing dedication and groundbreaking research, Jacobs remains a prominent figure in the development of effective veterinary vaccines.

This text is generated by artificial intelligence and may not be accurate.